Special legal opinion of Beijing Tianyuan Law Firm on the differentiated dividend of Beijing Joinn Laboratories Research Center Co., Ltd.
Response from KPMG Huazhen Certified Public Accountants (Special General Partnership) on the questions requested from accountants in the inquiry letter for the 2023 annual report of Beijing Zhaoyan New Drug Research Center Co., Ltd.
Announcement of Zhaoyan Pharmaceutical on holding a performance briefing for the first quarter of 2024
H Shares Announcement: Notice of Board Meeting
Beijing Zhaoyan New Drug Research Center Co., Ltd. Supplementary Explanatory Notice on Daily Continued Related Transactions
Announcement of Zhaoyan New Pharmaceutical on holding the 2023 Annual Results Briefing
Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd. Independent Director Work System (March 2024)
Zhaoyan New Pharmaceutical's 2023 Board Work Report
Zhaoyan New Pharmaceutical 2023 Supervisory Committee Work Report
Announcement of Resolutions of the 7th Meeting of the 4th Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd.
Announcement of Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd. on the renewal of the 2024 accounting firm
Announcement of Resolutions of the 6th Meeting of the Fourth Board of Supervisors of Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd.
2023 Audit Report of Zhaoyan New Pharmaceutical
2023 Annual Debriefing Report of the Independent Director of Zhaoyan New Pharmaceutical (Zhai Yonggong)
Zhaoyan New Pharmaceutical 2023 Internal Control Audit Report
Zhaoyan New Pharmaceutical 2023 Social Responsibility Report
2023 Annual Debriefing Report of the Independent Director of Zhaoyan Pharmaceutical (Sun Mingcheng)
2023 Annual Debriefing Report of the Independent Director of Zhaoyan Pharmaceutical (Ou Xiaojie)
Special opinion of the board of directors of Zhaoyan New Pharmaceutical on the independence of independent directors
Zhaoyan Pharmaceutical's 2023 Performance Evaluation Report on Accounting Firms
No Data